Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette Arnold

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
International Journal of Oncology|November 22, 2011
Newcastle disease virus induces pro-inflammatory conditions and type I interferon for counter-acting Treg activityPhilippe Fournier, Annette Arnold, Holger Wilden, et al.
International Journal of Cancer|August 19, 2005
A tumor vaccine containing anti-CD3 and anti-CD28 bispecific antibodies triggers strong and durable antitumor activity in human lymphocytesClaudia Haas, Maria Lulei, Philippe Fournier, et al.
Vaccine|March 9, 2005
T-cell triggering by CD3- and CD28-binding molecules linked to a human virus-modified tumor cell vaccineClaudia Haas, Maria Lulei, Philippe Fournier, et al.
Vaccine|July 21, 2009
Targeting anti-tumor DNA vaccines to dendritic cells via a short CD11c promoter sequenceJing Ni, Britta Nolte, Annette Arnold, et al.
International Journal of Cancer|February 14, 2006
Tumor selective replication of Newcastle disease virus: association with defects of tumor cells in antiviral defenceChristoph Fiola, Ben Peeters, Philippe Fournier, et al.
Molecular & Cellular Proteomics : MCP|December 21, 2025
Benchmarking Software for DDA-PASEF ImmunopeptidomicsYannic Chen, Annica Preikschat, Annette Arnold, et al.
Cancer Research|July 19, 2011
Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2Sonja Textor, Nathalie Fiegler, Annette Arnold, et al.
Briefings in Bioinformatics|March 20, 2025
REDInet: a temporal convolutional network-based classifier for A-to-I RNA editing detection harnessing million known eventsAdriano Fonzino, Pietro Luca Mazzacuva, Adam Handen, et al.
Blood|June 27, 2013
Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cellsNathalie Fiegler, Sonja Textor, Annette Arnold, et al.
International Journal of Oncology|September 25, 2008
Activation of human T cells by a tumor vaccine infected with recombinant Newcastle disease virus producing IL-2Markus Janke, Ben Peeters, Heng Zhao, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
International Journal of Oncology|November 22, 2011
Newcastle disease virus induces pro-inflammatory conditions and type I interferon for counter-acting Treg activityPhilippe Fournier, Annette Arnold, Holger Wilden, et al.
International Journal of Cancer|August 19, 2005
A tumor vaccine containing anti-CD3 and anti-CD28 bispecific antibodies triggers strong and durable antitumor activity in human lymphocytesClaudia Haas, Maria Lulei, Philippe Fournier, et al.
Vaccine|March 9, 2005
T-cell triggering by CD3- and CD28-binding molecules linked to a human virus-modified tumor cell vaccineClaudia Haas, Maria Lulei, Philippe Fournier, et al.
Vaccine|July 21, 2009
Targeting anti-tumor DNA vaccines to dendritic cells via a short CD11c promoter sequenceJing Ni, Britta Nolte, Annette Arnold, et al.
International Journal of Cancer|February 14, 2006
Tumor selective replication of Newcastle disease virus: association with defects of tumor cells in antiviral defenceChristoph Fiola, Ben Peeters, Philippe Fournier, et al.
Molecular & Cellular Proteomics : MCP|December 21, 2025
Benchmarking Software for DDA-PASEF ImmunopeptidomicsYannic Chen, Annica Preikschat, Annette Arnold, et al.
Cancer Research|July 19, 2011
Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2Sonja Textor, Nathalie Fiegler, Annette Arnold, et al.
Briefings in Bioinformatics|March 20, 2025
REDInet: a temporal convolutional network-based classifier for A-to-I RNA editing detection harnessing million known eventsAdriano Fonzino, Pietro Luca Mazzacuva, Adam Handen, et al.
Blood|June 27, 2013
Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cellsNathalie Fiegler, Sonja Textor, Annette Arnold, et al.
International Journal of Oncology|September 25, 2008
Activation of human T cells by a tumor vaccine infected with recombinant Newcastle disease virus producing IL-2Markus Janke, Ben Peeters, Heng Zhao, et al.
Pageof 2